{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:30:11Z","timestamp":1787567411003,"version":"build-2736575974"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Osteoporosis is a common age-related skeletal disorder characterized by low bone mass, deterioration of bone microarchitecture, and increased susceptibility to fragility fractures. Although antiresorptive and anabolic therapies have substantially improved fracture prevention, current treatments do not fully address the aging-related biological processes that disrupt skeletal homeostasis. Increasing evidence from osteoimmunology, immunosenescence, and cellular senescence research suggests that inflammaging contributes to age-related bone loss by reshaping the bone marrow immune microenvironment. Immune cells with senescence-associated features may promote bone remodeling imbalance through excessive production of senescence-associated secretory phenotype factors, including interleukin-1\u03b2, interleukin-6, tumor necrosis factor-\u03b1, chemokines, matrix-degrading enzymes, and receptor activator of nuclear factor-\u03baB ligand. These mediators enhance osteoclast differentiation and survival, impair osteoblast function, suppress osteogenic differentiation of bone marrow mesenchymal stromal cells, and propagate paracrine senescence within the bone marrow niche. Senolytics are pharmacological agents that selectively induce apoptosis in senescent cells by targeting senescent-cell anti-apoptotic pathways. Preclinical studies, including those using dasatinib plus quercetin, fisetin, and bone-targeted delivery platforms, have demonstrated the capacity to reduce global senescent-cell burden, attenuate SASP-related inflammation, and improve certain skeletal parameters in models of aging, postmenopausal osteoporosis, and radiotherapy-associated bone loss. However, it remains unclear whether these benefits arise from the elimination of immune cells with senescence-associated features, stromal cells, osteocytes, or a combination thereof. Critically, direct evidence that currently available senolytics selectively eliminate senescence-associated immune-cell subsets within the osteoporotic bone marrow is lacking. Early clinical evidence supports feasibility and hypothesis generation but does not yet establish senolytics as routine osteoporosis therapy. This narrative review synthesizes the mechanistic links among immunosenescence, inflammaging, immune cells with senescence-associated features, and bone remodeling imbalance; critically evaluates current preclinical and clinical evidence for senolytics in osteoporosis; and proposes a structured research roadmap\u2014centered on fate-mapping, lineage-specific depletion, and single-cell multi-omics\u2014to convert the prevailing hypothesis into experimentally testable and clinically actionable evidence, while delineating the translational challenges that must be overcome to achieve precision senolytic therapy.<\/jats:p>","DOI":"10.3389\/fendo.2026.1917096","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:11:18Z","timestamp":1787562678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Senescent immune cells, inflammaging, and bone loss: therapeutic potential and translational challenges of senolytics in osteoporosis"],"prefix":"10.3389","volume":"17","author":[{"given":"Minshun","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshan","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changping","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Lu\u2019an Hospital of Traditional Chinese Medicine","place":["Lu\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jama.2025.6003","article-title":"Osteoporosis: a review","volume":"334","author":"Morin","year":"2025","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06454-3","article-title":"Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis","volume":"33","author":"Xiao","year":"2022","journal-title":"Osteoporos Int"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society guideline update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2021.02.001","article-title":"American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"27","author":"Watts","year":"2021","journal-title":"Endocr Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12873","article-title":"Treating osteoporosis to prevent fractures: current concepts and future developments","volume":"285","author":"Lorentzon","year":"2019","journal-title":"J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0038","article-title":"Osteoimmunology: interactions of the bone and immune system","volume":"29","author":"Lorenzo","year":"2008","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","article-title":"Osteoimmunology: interplay between the immune system and bone metabolism","volume":"24","author":"Walsh","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000103","article-title":"T-cells and B-cells in osteoporosis","volume":"21","author":"Weitzmann","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00657","article-title":"Immunoporosis: immunology of osteoporosis-role of T cells","volume":"9","author":"Srivastava","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-037994","article-title":"B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo","volume":"109","author":"Li","year":"2007","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00465","article-title":"Osteoimmunology: the regulatory roles of T lymphocytes in osteoporosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17399","article-title":"Osteoimmunology: the correlation between osteoclasts and the Th17\/Treg balance in osteoporosis","volume":"26","author":"Huang","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.900028","article-title":"Immune senescence, immunosenescence and aging","volume":"3","author":"Lee","year":"2022","journal-title":"Front Aging"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030359","article-title":"Interconnections between inflammageing and immunosenescence during ageing","volume":"11","author":"Teissier","year":"2022","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-020-0173-8","article-title":"Contributions of age-related thymic involution to immunosenescence and inflammaging","volume":"17","author":"Thomas","year":"2020","journal-title":"Immun Ageing"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101422","article-title":"Immunosenescence and inflammaging in the aging process: age-related diseases or longevity","volume":"71","author":"Santoro","year":"2021","journal-title":"Ageing Res Rev"},{"key":"B20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-011620-034148","article-title":"B cell immunosenescence","volume":"36","author":"Frasca","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10522-014-9514-3","article-title":"Innate immunesenescence: underlying mechanisms and clinical relevance","volume":"16","author":"Hazeldine","year":"2015","journal-title":"Biogerontology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2017.12.020","article-title":"Inflammation and neutrophil immunosenescence in health and disease: targeted treatments to improve clinical outcomes in the elderly","volume":"105","author":"Drew","year":"2018","journal-title":"Exp Gerontol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature15367","article-title":"Neutrophil ageing is regulated by the microbiome","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-011-9366-z","article-title":"Cellular aging and senescence characteristics of human T-lymphocytes","volume":"13","author":"Onyema","year":"2012","journal-title":"Biogerontology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081742","article-title":"Markers of T cell senescence in humans","volume":"18","author":"Xu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0219","article-title":"Senescent T cells in age-related diseases","volume":"16","author":"Yu","year":"2024","journal-title":"Aging Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201948362","article-title":"CD28 and CD57 define four populations with distinct phenotypic properties within human CD8+ T cells","volume":"50","author":"Pangrazzi","year":"2020","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2023.106479","article-title":"Immunosenescence and macrophages: from basics to therapeutics","volume":"165","author":"Zhu","year":"2023","journal-title":"Int J Biochem Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-021-09936-9","article-title":"Perspectives on the dynamic implications of cellular senescence and immunosenescence on macrophage aging biology","volume":"22","author":"Sharma","year":"2021","journal-title":"Biogerontology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2024.0720","article-title":"Advancements in targeting macrophage senescence for age-associated conditions","volume":"16","author":"Xiao","year":"2024","journal-title":"Aging Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111588","article-title":"Astragaloside IV alleviates macrophage senescence and d-galactose-induced bone loss in mice through STING\/NF-\u03baB pathway","volume":"129","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2025.2534745","article-title":"Neutrophil extracellular traps drive osteoporosis via NCF2-dependent signaling: integrated transcriptomics with mechanistic validation","volume":"30","author":"Guo","year":"2025","journal-title":"Redox Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16227","article-title":"Neutrophil extracellular traps mediate bone erosion in rheumatoid arthritis by enhancing RANKL-induced osteoclastogenesis","volume":"181","author":"Schneider","year":"2024","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223568","article-title":"Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis","volume":"82","author":"O'Neil","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: from mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Copp\u00e9","year":"2008","journal-title":"PloS Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biology9120485","article-title":"The senescence-associated secretory phenotype (SASP) in the challenging future of cancer therapy and age-related diseases","volume":"9","author":"Cuollo","year":"2020","journal-title":"Biology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1101\/gad.343129.120","article-title":"Senescence and the SASP: many therapeutic avenues","volume":"34","author":"Birch","year":"2020","journal-title":"Genes Dev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2011.12.006","article-title":"Emerging role of NF-\u03baB signaling in the induction of senescence-associated secretory phenotype (SASP)","volume":"24","author":"Salminen","year":"2012","journal-title":"Cell Signal"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242317000","article-title":"Generating bone marrow chimeric mouse using GPR120 deficient mouse for the study of DHA inhibitory effect on osteoclast formation and bone resorption","volume":"24","author":"Ma","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2026.150784","article-title":"Bifidobacterium animalis RH exopolysaccharide bidirectionally modulates inflammatory bone metabolism disorders","volume":"349","author":"Shi","year":"2026","journal-title":"Int J Biol Macromol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41526-021-00146-8","article-title":"Trabecular bone organoids: a micron-scale 'humanised' prototype designed to study the effects of microgravity and degeneration","volume":"7","author":"Iordachescu","year":"2021","journal-title":"NPJ Microgravity"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00788","article-title":"Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma","volume":"9","author":"Harmer","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65885","article-title":"Assessing the effect of exogenous melatonin on orthodontic tooth movement","volume":"16","author":"Thiagarajan","year":"2024","journal-title":"Cureus"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051150","article-title":"Autoamplification of NFATc1 expression determines its essential role in bone homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"J Exp Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.2018025874","article-title":"Does TNF promote or restrain osteoclastogenesis and inflammatory bone resorption","volume":"38","author":"Zhao","year":"2018","journal-title":"Crit Rev Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2892","article-title":"Identification of senescent cells in the bone microenvironment","volume":"31","author":"Farr","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4385","article-title":"Targeting cellular senescence prevents age-related bone loss in mice","volume":"23","author":"Farr","year":"2017","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.01.015","article-title":"Cellular senescence in bone","volume":"121","author":"Farr","year":"2019","journal-title":"Bone"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-020-00619-x","article-title":"Osteocyte cellular senescence","volume":"18","author":"Farr","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10488","article-title":"Bone aging, cellular senescence, and osteoporosis","volume":"5","author":"Pignolo","year":"2021","journal-title":"JBMR Plus"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052701","article-title":"Age related osteoporosis: Targeting cellular senescence","volume":"23","author":"F\u00f6ger-Samwald","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13323","article-title":"Senescent cells: A therapeutic target for osteoporosis","volume":"55","author":"Wang","year":"2022","journal-title":"Cell Prolif"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3978","article-title":"Targeted reduction of senescent cell burden alleviates focal radiotherapy-related bone loss","volume":"35","author":"Chandra","year":"2020","journal-title":"J Bone Miner Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/jbmr.4537","article-title":"Bone marrow adiposity in models of radiation- and aging-related bone loss is dependent on cellular senescence","volume":"37","author":"Chandra","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81480","article-title":"Osteocytes regulate senescence of bone and bone marrow","volume":"11","author":"Ding","year":"2022","journal-title":"eLife"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12344","article-title":"The Achilles' heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12445","article-title":"Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors","volume":"15","author":"Zhu","year":"2016","journal-title":"Aging Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","article-title":"Fisetin is a senotherapeutic that extends health and lifespan","volume":"36","author":"Yousefzadeh","year":"2018","journal-title":"EBioMedicine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","article-title":"Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging","volume":"169","author":"Baar","year":"2017","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13141","article-title":"Senolytic drugs: from discovery to translation","volume":"288","author":"Kirkland","year":"2020","journal-title":"J Intern Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.05.003","article-title":"Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases","volume":"171","author":"Lagoumtzi","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111591","article-title":"Strategies for late phase preclinical and early clinical trials of senolytics","volume":"200","author":"Wissler Gerdes","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"B70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bioactmat.2023.01.009","article-title":"Repurpose dasatinib and quercetin: Targeting senescent cells ameliorates postmenopausal osteoporosis and rejuvenates bone regeneration","volume":"25","author":"Wang","year":"2023","journal-title":"Bioact Mater"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.devcel.2026.04.004","article-title":"An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA","volume":"61","author":"Demaria","year":"2026","journal-title":"Dev Cell"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.10.019","article-title":"Programmed cell senescence during mammalian embryonic development","volume":"155","author":"Mu\u00f1oz-Esp\u00edn","year":"2013","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2026.03.005","article-title":"Senescence in cancer: Hallmarks, paradoxes, and therapeutic promise","volume":"189","author":"Hinterleitner","year":"2026","journal-title":"Cell"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.5650\/jos.ess21252","article-title":"Anti-osteoporosis effect of fisetin against ovariectomy induced osteoporosis in rats: In silico, in vitro and in vivo activity","volume":"71","author":"Feng","year":"2022","journal-title":"J Oleo Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00354","article-title":"The senolytic drug navitoclax (ABT-263) causes trabecular bone loss and impaired osteoprogenitor function in aged mice","volume":"8","author":"Sharma","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2022.11.056","article-title":"Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis","volume":"157","author":"Xing","year":"2023","journal-title":"Acta Biomater"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03096-2","article-title":"Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial","volume":"30","author":"Farr","year":"2024","journal-title":"Nat Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1917096\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:11:19Z","timestamp":1787562679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1917096\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":78,"alternative-id":["10.3389\/fendo.2026.1917096"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1917096","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"article-number":"1917096"}}